(CNN) -- Today was a strange day. I'm used to handling the brief but overwhelming burst of media attention that comes with new stories about medical breakthroughs and ethical issues. But I don't often get an accompanying deluge of passionate e-mails and phone calls from people who had read my comments, denouncing me for criticizing science, especially medical research that "can save millions of lives."
There is definitely something special about this idea of "therapeutic cloning," something that has a religious feel to it. Most of those messages come from people who have family members suffering from some of the diseases that we are told will be cured, and it's hard to have to pour cold water on people's hopes.
I feel really angry at the scientists and PR people who have sold the idea of cloned human stem cells to so many patient support groups, when there is so little scientific substance to their promises. We are told that there will be great medical benefits and that the risks that there will be cloned babies are small, but in...
A Mexican standoff with the United States turned into a Mexican smack-down this month with the release of Mexico’s formal rebuttal to US efforts to overturn limits Mexico has ordered on the use of genetically modified (GM) corn and the...
The U.S. government must move “quickly and decisively” to avert substantial national security risks stemming from artificial intelligence (AI) which could, in the worst case, cause an “extinction-level threat to the human species,” says a report commissioned by the U.S...
By Nada Hassanein, New Jersey Monitor | 03.14.2024
Aggregated News
The U.S. Food and Drug Administration late last year approved two breakthrough gene therapies for sickle cell disease patients. Now a new federal program seeks to make these life-changing treatments available to patients with low incomes — and it could...
The Center for Genetics and Society is fiscally sponsored by Tides Center, a 501(c)(3) non-profit organization.
Please visit www.tides.org/state-nonprofit-disclosures for additional information.
